|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.16 GBX | -2.96% |
|
-0.80% | -5.02% |
| 06-10 | Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test | AN |
| 06-10 | IXICO plc Announces FDA Clearance of New Alzheimer's Disease Blood Based Diagnostic Biomarker | CI |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- IXI Stock
- News IXICO plc
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition